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Background: CMR is considered the ‘gold standard’ for non-invasive LV and RV mass quantitation. To our knowledge, this information is solely 
based on GRE sequences. SSFP, with contrast dependent on intrinsic T1/T2 characteristics, potentially offers superior contrast between blood and 
myocardium. Here we validate a post-heart orthotopic heart transplant (ORTx) approach.
objective: To establish a correlation between SSFP-CMR derived LV and RV mass vs. autopsy mass of ex vivo hearts from ORTX patients.
Methods: Over a three-year period, 58 explanted hearts were obtained immediately upon ORTx from the OR. They were quickly cleaned and 
suspended in a saline-filled container and scanned ex vivo via SSFP-SA slices defining CMR LV/RV mass (g). Using a readily available automatic 
thresholding program, segmentation of the slices was achieved in combination with manual trimming (ATMT) of the extraneous tissue using a 3D 
model by an independent and blinded reader (implemented on a 1.5 GE model, Milwaukee, WI). The hearts were then dissected with LV and RV 
surgically separated at the intraventricular septum. The weight of the total including papillary and trabecular myocardium, LV and RV was measured 
via high-fidelity scale. Correlation between the 3D CMR method and pathology were performed along with Bland-Altman plots.
results: Of the 58 explanted hearts, 3 (5%) were excluded due to poor image quality (peri-surgical destruction) leaving 55 (95%) for the final 
analysis. Extreme positive correlations were obtained between total CMR 3D mass (450±111g) and total pathology mass (445±116g; r=0.99, 
p<.001) and the 3D CMR measured LV mass (301±93g) versus the pathology measured LV mass (313±96g; r =0.95, p<.001). Strong positive 
correlation was demonstrated between the 3D CMR measured RV mass (149±46g) and the pathology measured RV mass (128±40g; r = 0.76, 
p<.001). The equation y=1.02x -15.2b regressed the total cardiac mass (r = 0.99).
conclusions: SSFP-CMR accurately determines total LV and RV masses as compared to weighed explanted hearts, despite variable surgical 
removal of instrumentation (LVAD/RVAD, AICD’s and often apical core removals). Thus, this becomes the first-ever human ‘gold-standard’ 
confirmation.
